Skip to content

Alumis Inc. ALMS Total debt

Total debt at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$1.81M+90.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$1.91M-44.3%
Vera Therapeutics logo
Vera TherapeuticsVERA
$75.03M+37.8%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.36M-2.3%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.12B+739%
Enterprise value$3.1B+1,238%
P/S371.9×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $35.66M.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s total debt?
Alumis Inc. (ALMS) reported total debt of $35.66M in Q1 2026.
How has Alumis Inc.'s total debt changed year-over-year?
Alumis Inc.'s total debt increased by 1881.3% year-over-year, from $1.8M to $35.66M.
What is the long-term trend for Alumis Inc.'s total debt?
Over 2 years (2023 to 2025), Alumis Inc.'s total debt has grown at a 6.4% compound annual growth rate (CAGR), from $32.58M to $36.91M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.